Nov 30, 2025
Most ViewedWhich state pharmacy boards have issued formal guidance or advisories specifically addressing compounding of GLP-1/GIP analogs (e.g., tirzepatide) since 2023?
State pharmacy boards and related state regulators issued spot guidance and advisories about compounding GLP‑1/GIP analogs beginning in 2023 and accelerating through 2024–2025 as FDA moved from shorta...